Abbott's stent withdrawal plea rejected
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
The National Pharmaceutical Pricing Authority (NPPA) has rejected US-based stent maker Abbott’s application to withdraw its high-end stents from India on technical grounds, asking it to re-apply if it still wanted to pull out. But, the rejection has come with a possible sweetener. In an indication of a softening of stand, the NPPA told Abbott that it should prove the superiority of its stents if it wanted a better price.

At present, the price cap at Rs 29,600 is meant for all stents, irrespective of make and origin.

http://www.business-standard.com/article/companies/abbott-s-stent-withdrawal-plea-rejected-117042601494_1.html
Preview
Like
Comment
Share